🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

RecruitingNAAges 18 Years - anyAllInstitut Claudius Regaud
NCT04940000 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age ≥ 18 years at study entry. 2. Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy. 3. Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). 4. Patient affiliated to a Social Security system in France. 5. Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedure. Exclusion Criteria: 1. Pregnant or lactating women. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
💊

What it tests

  • Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
📍

Where

1 site
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy